AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12646763 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) administration of 2 mg clonazepam
Number of subjects: 12
Study 10728943 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise conditioning (exercise group)
Number of subjects: 641
Study 10728943 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 641
Study 10728943 — intervention group
Group type: EXPERIMENTAL
Intervention: Low MESP group
Number of subjects: 641
Study 8807096 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral blood stem cell transplantation (PBSCT) following high-dose chemoradiotherapy
Number of subjects: 40
Study 8807096 — intervention group
Group type: COMPARATOR
Intervention: Debulking chemotherapy (vincristine, adriamycin, and dexamethasone or methylprednisolone)
Number of subjects: 40
Study 8807096 — intervention group
Group type: COMPARATOR
Intervention: High-dose cyclophosphamide for stem cell mobilization
Number of subjects: 40
Study 8807096 — intervention group
Group type: EXPERIMENTAL
Intervention: PBSCT
Number of subjects: 40
Study 8807096 — intervention group
Group type: COMPARATOR
Intervention: Low serum B2M before mobilization
Number of subjects: 40
Study 1381611 — intervention group
Group type: EXPERIMENTAL
Intervention: arotinolol (10 mg bid)
Number of subjects: 10
Study 1381611 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 6208185 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 49
Study 6208185 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 49
Study 6208185 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 49
Study 6208185 — intervention group
Group type: COMPARATOR
Intervention: Neither drug
Number of subjects: 49
Study 31271885 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus/Sirolimus (Tac/Sir)
Number of subjects: 304
Study 31271885 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus/Methotrexate (Tac/MTX)
Number of subjects: 304
Study 27798510 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab on top of standard treatment (calcium and vitamin D), n = 46
Number of subjects: 90
Study 27798510 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone, n = 44
Number of subjects: 90
Study 27798510 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 90
Study 27798510 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 90
Study 25953802 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegnivacogin followed by anivamersen
Number of subjects: 14
Study 25953802 — intervention group
Group type: COMPARATOR
Intervention: Heparin/protamine
Number of subjects: 14
Study 26330894 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-hour repositioning schedule
Number of subjects: 123
Study 26330894 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hour repositioning schedule
Number of subjects: 123
Study 21360104 — intervention group
Group type: EXPERIMENTAL
Intervention: Double crowns
Number of subjects: 25
Study 19528902 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise (60% VO(2) max)
Number of subjects: 18
Study 19528902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive exercise (75% VO(2) max)
Number of subjects: 18
Study 17505157 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (2.5‐7.5 mg/day)
Number of subjects: 14
Study 17505157 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 14
Study 15702855 — intervention group
Group type: EXPERIMENTAL
Intervention: Cornstarch thickened casein predominant formula
Number of subjects: 96
Study 15702855 — intervention group
Group type: COMPARATOR
Intervention: Regular infant formula
Number of subjects: 96
Study 12843887 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of general and long‐acting local‐regional anesthesia with the 'bi‐clamp' procedure for bipolar electrosurgery
Number of subjects: 0
Study 10916043 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine agonists (bromocriptine, lisuride, cabergoline, ropinirole)
Number of subjects: 0
Study 10916043 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of L-dopa (added as a second step if necessary)
Number of subjects: 0
Study 10916043 — intervention group
Group type: COMPARATOR
Intervention: Dopamine agonists
Number of subjects: 0
Study 8885585 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion 3 to 6 mg/kg per day, administered twice daily
Number of subjects: 109
Study 8885585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 1497527 — intervention group
Group type: EXPERIMENTAL
Intervention: In-the-bag fixation
Number of subjects: 0
Study 1497527 — intervention group
Group type: COMPARATOR
Intervention: Out-of-the-bag fixation
Number of subjects: 0
Study 6389006 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure delivered by mask
Number of subjects: 38
Study 6389006 — intervention group
Group type: COMPARATOR
Intervention: Incentive spirometry
Number of subjects: 38
Study 6389006 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 38
Study 6389006 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall incidence of pneumonia
Number of subjects: 38
Study 30273448 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum aiTBS
Number of subjects: 0
Study 30273448 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 28792260 — intervention group
Group type: EXPERIMENTAL
Intervention: P-ICE (panobinostat + ifosfamide + carboplatin + etoposide)
Number of subjects: 23
Study 27485509 — intervention group
Group type: EXPERIMENTAL
Intervention: a-la-carte self-management program
Number of subjects: 50
Study 27485509 — intervention group
Group type: COMPARATOR
Intervention: set menu control group
Number of subjects: 50
Study 27485509 — intervention group
Group type: COMPARATOR
Intervention: usual care control group
Number of subjects: 50
Study 24838894 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 21
Study 24838894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 22120301 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant autologous dendritic cell vaccine
Number of subjects: 34
Study 22120301 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment only (Control group)
Number of subjects: 34
Study 20649614 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldmann Applanation Tonometry (GAT)
Number of subjects: 38
Study 20649614 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Contour Tonometry (DCT)
Number of subjects: 38
Study 20649614 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 38
Study 20649614 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoexfoliative Group (PG)
Number of subjects: 38
Study 17562405 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite/tricalcium-phosphate-coated stems
Number of subjects: 84
Study 17562405 — intervention group
Group type: COMPARATOR
Intervention: Noncoated stems
Number of subjects: 84
Study 16201160 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique (electrode placement 4 cm distal to ASIS)
Number of subjects: 20
Study 16201160 — intervention group
Group type: COMPARATOR
Intervention: Old technique (electrode placement 1 cm medial to ASIS)
Number of subjects: 20
Study 12197840 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with interferon‐α 2a/2b plus ribavirin
Number of subjects: 1728
Study 12197840 — intervention group
Group type: COMPARATOR
Intervention: Interferon monotherapy
Number of subjects: 1728
Study 9927366 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min spontaneous breathing trial
Number of subjects: 526
Study 9927366 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-min spontaneous breathing trial
Number of subjects: 526
Study 9927366 — intervention group
Group type: EXPERIMENTAL
Intervention: Reintubation
Number of subjects: 526
Study 7569755 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole (40 mg)
Number of subjects: 266
Study 7569755 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (300 mg)
Number of subjects: 266
Study 2405090 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 104
Study 2405090 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 104
Study 2405090 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril + Bendroflumethiazide
Number of subjects: 104
Study 2405090 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol + Bendroflumethiazide
Number of subjects: 104
Study 6781156 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination of dihydralazin and propranolol
Number of subjects: 36
Study 6781156 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive standard therapy
Number of subjects: 36
Study 31583977 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation video intervention
Number of subjects: 30
Study 31583977 — intervention group
Group type: COMPARATOR
Intervention: Discussion about disease (Control)
Number of subjects: 30
Study 29480916 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT) for a maximum of 20 minutes
Number of subjects: 60
Study 29480916 — intervention group
Group type: COMPARATOR
Intervention: Seated Control (waiting for 30 minutes)
Number of subjects: 60
Study 29480916 — intervention group
Group type: COMPARATOR
Intervention: Walking Control (walking for 5 minutes)
Number of subjects: 60
Study 29480916 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (OMT, seated control, walking control)
Number of subjects: 60
Study 29480916 — intervention group
Group type: EXPERIMENTAL
Intervention: Palpatory assessment of SBP and SSD
Number of subjects: 60
Study 29141653 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescriber Recruitment Bundle (PRB) intervention implemented over a 24-month period with a 10-month sustainability period.
Number of subjects: 70
Study 29141653 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual with access to a website with PRB resources.
Number of subjects: 70
Study 26090709 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic rollerskiing technique
Number of subjects: 7
Study 26090709 — intervention group
Group type: EXPERIMENTAL
Intervention: Skate rollerskiing technique
Number of subjects: 7
Study 26090709 — intervention group
Group type: COMPARATOR
Intervention: Both techniques (classic and skate)
Number of subjects: 7
Study 23168372 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR-RE
Number of subjects: 27
Study 23168372 — intervention group
Group type: COMPARATOR
Intervention: RE
Number of subjects: 27
Study 21102387 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane-based inhalational anesthesia
Number of subjects: 30
Study 21102387 — intervention group
Group type: COMPARATOR
Intervention: Intravenous anesthesia with propofol
Number of subjects: 30
Study 19378515 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg kg(‐1) of rocuronium (1 ED95)
Number of subjects: 60
Study 19378515 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg kg(‐1) of rocuronium (2 ED95)
Number of subjects: 60
Study 15901044 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (25 mg carvedilol tablets)
Number of subjects: 24
Study 15901044 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (25 mg carvedilol tablets)
Number of subjects: 24
Study 14642046 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral rotoresection (TURotor; N = 58)
Number of subjects: 128
Study 14642046 — intervention group
Group type: COMPARATOR
Intervention: Standard transurethral resection of the prostate (TURP; N = 70)
Number of subjects: 128
Study 11107080 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective AAA repair (eAAA)
Number of subjects: 0
Study 11107080 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruptured AAA repair (rAAA)
Number of subjects: 0
Study 11107080 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of death from eAAA
Number of subjects: 0
Study 11107080 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of death from rAAA
Number of subjects: 0
Study 8799402 — intervention group
Group type: EXPERIMENTAL
Intervention: OKY 046 (0.2 mg/kg/hr)
Number of subjects: 22
Study 8799402 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drug given)
Number of subjects: 22
Study 1623908 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 200 micrograms orally + placebo i.v.
Number of subjects: 10
Study 1623908 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 200 micrograms orally + naloxone i.v. (2.8 mg/5 h)
Number of subjects: 10
Study 1623908 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo i.v.)
Number of subjects: 10
Study 1623908 — intervention group
Group type: COMPARATOR
Intervention: Control (naloxone i.v.)
Number of subjects: 10
Study 6386002 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (225 mg/day) and Aspirin (975 mg/day)
Number of subjects: 28
Study 6386002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 6386002 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole and Aspirin
Number of subjects: 28
Study 30976908 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dosing of palonosetron (0.075 mg)
Number of subjects: 51
Study 30976908 — intervention group
Group type: COMPARATOR
Intervention: Body size‐based dosing of palonosetron
Number of subjects: 51
Study 30976908 — intervention group
Group type: EXPERIMENTAL
Intervention: LBW-based dosing of palonosetron
Number of subjects: 51
Study 30410128 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone injection followed by dilatation
Number of subjects: 60
Study 30410128 — intervention group
Group type: COMPARATOR
Intervention: Dilatation alone
Number of subjects: 60
Study 27869358 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 1379
Study 27869358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1379
Study 27869358 — intervention group
Group type: COMPARATOR
Intervention: Washout
Number of subjects: 1379
Study 23434617 — intervention group
Group type: EXPERIMENTAL
Intervention: High ligation and stripping (HL&S)
Number of subjects: 45
Study 23434617 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation with ClosureFast (RFA)
Number of subjects: 45
Study 23434617 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 45
Study 22971669 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 30 mg/d
Number of subjects: 308
Study 22971669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 19428118 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 223
Study 19428118 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 223
Study 19428118 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 223
Study 18841533 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue-based feeding (intervention group)
Number of subjects: 79
Study 18841533 — intervention group
Group type: COMPARATOR
Intervention: Traditional feeding regimen (control group)
Number of subjects: 79
Study 16970087 — intervention group
Group type: EXPERIMENTAL
Intervention: Yanshu Injection (20 ml daily)
Number of subjects: 150
Study 12814448 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan administered by intravenous infusion
Number of subjects: 190
Study 11227684 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy intervention during the first dressing change (Group A)
Number of subjects: 25
Study 11227684 — intervention group
Group type: COMPARATOR
Intervention: No music therapy intervention during the first dressing change (Group B)
Number of subjects: 25
Study 9140019 — intervention group
Group type: COMPARATOR
Intervention: Melatonin (5 mg)
Number of subjects: 0
Study 9140019 — intervention group
Group type: COMPARATOR
Intervention: S-20098 (5 mg and 100 mg)
Number of subjects: 0
Study 9140019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7956632 — intervention group
Group type: EXPERIMENTAL
Intervention: DQB1*0201 and DQB1*0302 alleles
Number of subjects: 48
Study 7956632 — intervention group
Group type: EXPERIMENTAL
Intervention: DQB1*0301 and DQB1*0601 alleles
Number of subjects: 48
Study 7956632 — intervention group
Group type: EXPERIMENTAL
Intervention: Homozygous non‐aspartic acid residue (NA/NA) at position 57
Number of subjects: 48
Study 7956632 — intervention group
Group type: EXPERIMENTAL
Intervention: Homozygous aspartic acid (A/A) at position 57
Number of subjects: 48
Study 7956632 — intervention group
Group type: EXPERIMENTAL
Intervention: DQB1*0201/DQB1*0303 genotype among NA/A heterozygotes
Number of subjects: 48
Study 3654132 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mL antiseptic soap
Number of subjects: 40
Study 3654132 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mL antiseptic soap
Number of subjects: 40
Study 3654132 — intervention group
Group type: COMPARATOR
Intervention: Control liquid soap
Number of subjects: 40
Study 3654132 — intervention group
Group type: EXPERIMENTAL
Intervention: General population and nursing staff
Number of subjects: 40
Study 30805607 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy Drink (ED)
Number of subjects: 38
Study 30805607 — intervention group
Group type: COMPARATOR
Intervention: Control Product (CP)
Number of subjects: 38
Study 30805607 — intervention group
Group type: COMPARATOR
Intervention: Control Product (CP) supplemented with ED-ingredients
Number of subjects: 38
Study 30805607 — intervention group
Group type: EXPERIMENTAL
Intervention: All study products
Number of subjects: 38
Study 28284187 — intervention group
Group type: EXPERIMENTAL
Intervention: RISKIT-CJS intervention in addition to treatment as usual
Number of subjects: 0
Study 28284187 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual alone
Number of subjects: 0
Study 25218352 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPU repair with dorsal dartos flap
Number of subjects: 214
Study 25218352 — intervention group
Group type: COMPARATOR
Intervention: Flapless TIPU repair
Number of subjects: 214
Study 23958469 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-informed implementation intervention (interactive, opinion leader-led, educational face-to-face workshop)
Number of subjects: 60
Study 23958469 — intervention group
Group type: COMPARATOR
Intervention: Printed copy of the guideline (control group)
Number of subjects: 60
Study 21848415 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsing electromagnetic generator
Number of subjects: 117
Study 19390517 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet (D group; n = 9)
Number of subjects: 18
Study 19390517 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet + Exercise (D+E group; n = 9)
Number of subjects: 18
Study 19390517 — intervention group
Group type: COMPARATOR
Intervention: Control (D group)
Number of subjects: 18
Study 16396771 — intervention group
Group type: EXPERIMENTAL
Intervention: ViGePP regimen (gemcitabine, vinorelbine, procarbazine, and prednisone) administered every 4 weeks up to six courses.
Number of subjects: 69
Study 15282264 — intervention group
Group type: EXPERIMENTAL
Intervention: Estropipate (an estrogen substitute)
Number of subjects: 0
Study 15282264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11531149 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-meal interval of 15 min
Number of subjects: 11
Study 11531149 — intervention group
Group type: COMPARATOR
Intervention: Insulin-meal interval of 30 min
Number of subjects: 11
Study 9280186 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg/d as amino acid chelate for 3 weeks)
Number of subjects: 20
Study 9280186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9280186 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 20
Study 8285322 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 47
Study 8285322 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 47
Study 30452427 — intervention group
Group type: EXPERIMENTAL
Intervention: PD training using a PD simulator
Number of subjects: 28
Study 30452427 — intervention group
Group type: COMPARATOR
Intervention: Videos for PD training (Control)
Number of subjects: 28
Study 30452427 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (PD simulator)
Number of subjects: 28
Study 29735880 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training (10 sessions, 30 minutes each, involving high-beta, theta, and sensory motor rhythm training)
Number of subjects: 78
Study 29735880 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training
Number of subjects: 78
Study 27009070 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT screening (T0)
Number of subjects: 26231
Study 27009070 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT screening (T1)
Number of subjects: 26231
Study 25042307 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Group (EG)
Number of subjects: 42
Study 25042307 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 42
Study 22108915 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg oral estradiol (n=6)
Number of subjects: 11
Study 22108915 — intervention group
Group type: COMPARATOR
Intervention: 50 μg/day transdermal 17β‐estradiol (n=5)
Number of subjects: 11
Study 20404290 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation group (n = 30) received a tape of their consultation interview
Number of subjects: 84
Study 20404290 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic group (n = 25) received a tape about coronary artery surgery
Number of subjects: 84
Study 20404290 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 29) received no tape
Number of subjects: 84
Study 18028044 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl iontophoretic transdermal system (ITS) (40 microg fentanyl/dose)
Number of subjects: 506
Study 18028044 — intervention group
Group type: COMPARATOR
Intervention: Morphine intravenous patient-controlled analgesia (IV PCA) (1 mg morphine/dose)
Number of subjects: 506